Old Web
English
Sign In
Acemap
>
authorDetail
>
Cheryl Forder
Cheryl Forder
AstraZeneca
Cyclin-dependent kinase
Kinase
Pharmacology
Molecular biology
Cell cycle
5
Papers
139
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Structure of the Tie2 kinase domain in complex with a thiazolopyrimidine inhibitor
2009
C. Brassington
Jason Breed
David Buttar
Martina Fitzek
Cheryl Forder
Lorraine Hassall
Barry R. Hayter
Clifford David Jones
Richard William Arthur Luke
Eileen McCall
William Mccoull
Richard A. Norman
D. Paterson
Helen McMiken
Sian Rowsell
J.A. Tucker
Show All
Source
Cite
Save
Citations (0)
Discovery of imidazole vinyl pyrimidines as a novel class of kinase inhibitors which inhibit Tie-2 and are orally bioavailable.
2008
Bioorganic & Medicinal Chemistry Letters
David Buttar
Mike Edge
Steve Emery
Martina Fitzek
Cheryl Forder
Alison M. Griffen
Barry R. Hayter
Christopher F. Hayward
Philip Hopcroft
Richard William Arthur Luke
Ken Page
John Stawpert
Andy Wright
Show All
Source
Cite
Save
Citations (7)
A phase I pharmacodynamic study of the effects of the cyclin-dependent kinase-inhibitor AZD5438 on cell cycle markers within the buccal mucosa, plucked scalp hairs and peripheral blood mononucleocytes of healthy male volunteers
2007
Cancer Chemotherapy and Pharmacology
D. Ross Camidge
M N Pemberton
Jim Growcott
Dereck Amakye
David Matthew Wilson
Helen Swaisland
Cheryl Forder
Robert W. Wilkinson
Kate Byth
Andrew Hughes
Show All
Source
Cite
Save
Citations (23)
1